Risk Management in Clinical and Biochemical Laboratories During the Covid-19 Pandemic
Abstract
The COVID-19 pandemic is a major challenge for clinical-biochemical laboratories. Laboratory managers face demands to maintain the productivity and quality of laboratory diagnostics, while protecting laboratory staff from a new pathogen that the medical public has only just begun to reveal. This paper describes the experiences of the Center for Medical Biochemistry of the University Medical Center of Serbia (CMB UCCS) in risk management during the COVID-19 pandemic. During the pandemic, this reference center, the first accredited laboratory in Serbia, provided more than 4.5 million tests in the field of modern laboratory diagnostics for COVID-19 patients. The paper will describe a site- and activity-specific risk assessment of the laboratory to identify and mitigate risks, measures to protect against potential risks from infectious samples, with a focus on staff safety and prevention of biohazard exposure. CMB UCCS risk management strategy based on IFCC, WHO, CLSI M29A4 risk management recommendations will be analyzed. From today’s viewpoint, the main precondition for successful risk management during a pandemic is the timely provision of laboratory facilities, i.e. that laboratories should have enough staff to be flexible in their work, that the staff have adequate protective equipment and resources for work, and that managers are experienced and ready to work effectively in crisis situations, taking into account the implementation of motivation strategies and promoting the mental and physical health of employees.
References
Adeli, K. (2020). Critical role of laboratory medicine in the global response to the COVID-19 pandemic. Clinical Chemistry and Laboratory Medicine, 58(7):1019–1020. https://doi.org/10.1515/cclm-2020-0742
American Biological Safety Association International (ABSA). (2020). Considerations for Handling Potential SARS-CoV-2 Samples.
American Society for Microbiology;Association of Public Health Laboratories (U.S.);Centers for Disease Control and Prevention (U.S.); Sentinel level clinical microbiology laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases:Bacillus anthracis (2010): Available at: https://stacks.cdc.gov/view/cdc/30727. Last accessed: March 15, 2022.
Association of Public Health Laboratories. Risk assessment best practices. Available at: https://www.aphl.org/programs/preparedness/Documents/APHL%20Risk%20Assessment %20Best%20Practices%20and%20Examples.pdf. Last accessed: March 2020.
Bowdle, A., & Munoz-Price, LS. (2020). Preventing infection of patients and healthcare workers should be the new normal in the era of novel coronavirus epidemics. Anesthesiology, 132(6):1292–1295. https://doi.org/10.1097/ALN.0000000000003295
Centers for Disease Control and Prevention (CDC). (2020). Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19). Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/lab-biosafety-guidelines.html. Last accessed: December 15, 2021.
Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) – How Coronavirus Spreads. Available at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-gettingsick/how-covid-spreads.html. Last accessed: April 1, 2020.
Chin, A.W.H., Chu, J.T.S., Perera, M.R.A., Hui, K.P.Y., Yen, H.L., Chan, M.C.W., Peiris, M., & Poon, L.L.M. (2020)- Stability of SARS-CoV-2 in different environmental conditions. The Lancet Microbe, 1(1), e10. https://doi. org/10.1016/S2666-5247(20)30003-3.
CLSI. Laboratory quality control based on risk management; approved guideline. CLSI document EP23-A. Wayne, PA: CLSI; 2011.
CLSI. Protection of laboratory workers from occupationally acquired infections, CLSI M29. 4th ed. Wayne, PA: CLSI; 2014.
European Centre for Disease Prevention and Control (ECDC). (2020). Infection prevention and control and preparedness for COVID-19 in healthcare settings – second update. 31 March 2020. ECDC: Stockholm; 2020.
First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU). Handbook of COVID-19 Prevention and Treatment.
Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection, 104, 246–251.
Kratzel, A., Todt, D., V'kovski, P., Steiner, S., Gultom, M., Thao, TTN., Ebert, N., Holwerda, M., Steinmann, J., Niemeyer, D., Dijkman, R., Kampf, G., Drosten, C., Steinmann, E., Thiel, V., & Pfaender S. (2020). Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols. Emergency Infectious Diseases, 26(7), 1592-1595. https://doi.org/10.3201/eid2607.200915.
Lippi, G., Adeli, K., Ferrari, M., Horvath, R, Koch, D., Sethi, S. & Wang, C.B. (2020). Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations. Clinical Chemistry and Laboratory Medicine, 58(7),1053–1062. https://doi.org/10.1515/cclm-2020-0633.
Loh, T.P., Horvath, A.R., Wang, C.B., Koch, D., Lippi, G., Mancini, N., Ferrari, M., Hawkins, R., Sethi, S. & Adeli, K.; International Federation of Clinical Chemistry and Laboratory Medicine Taskforce on COVID-19. (2020). Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey. Clinical Chemistry and Laboratory Medicine, 58(9),1433–1440. https://doi.org/10.1515/cclm-2020-0711
Ma, Q. X., Shan, H., Zhang, H. L., Li, G. M., Yang, R. M., & Chen, J. M. (2020). Potential utilities of mask-wearing and instant hand hygiene for fighting SARS-CoV-2. Journal of medical virology, 92(9), 1567–1571. https://doi.org/10.1002/jmv.25805.
Oğuzhan, Z., Guzin, A., Cihan, C., Muhittin, S. & Dogan, Y. (2020) COVID-19 laboratory biosafety guide. Turkish Journal of Biochemistry, 45(4): 461–463.
Ong, S.W.X., Tan, Y.K., Sutjipto, S., Chi,a P.Y., Young, B.E., Gum, M., Lau, S.K., Chan, M., Vasoo, S., Mendis, S., Toh, B.K., Leong, J., Barkham, T., Ang, B.S.P., Tan, B.H., Leo, Y.S., Marimuthu, K., Wong, M.S.Y., Ng, O.T. (2020). Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection Control and Hospital Epidemiology, 41(5), 614-616. https://doi.org/10.1017/ice.2020.91.
Public Health England (PHE). COVID-19: safe handling and processing for samples in laboratories. Updated 28 March 2020.
Stanković, S., Ašanin, M. (2021). Clinical laboratories in the era of the Covid-19. Pandemic: an analysis of experiences in Serbia Srpski medicinski časopis Lekarske komore, 3(2), 286–294.
The Therapeutic Goods Administration (TGA). Appropriate use of disinfectants: Information for consumers, health professionals and healthcare facilities. Available at: https://www.tga.gov.au/ appropriate-use-disinfectants-information-consumers-healthprofessionals-and-healthcare-facilities. Last accessed: 27 April 2020.
World Health organization (WHO). (2020). Rational use of personal protective equipment for Coronavirus disease 2019 (COVID-19) – Interim guidance 27 February 2020.
World Health Organization. Coronavirus disease (COVID-2019) situation reports. Available at: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/situation-reports. Last accessed: April 29, 2020.